|
|
Question: From El Paso, Texas, USA:
Do thiazolidinediones cause a so-called fatty liver?
Answer:
Rezulin [Rezulin, a pill for type 2 diabetes] was withdrawn from the market because of a rare, but potentially fatal, risk of drug-induced liver failure. The mechanism of the liver failure was not predictable. The other medications from the same group that are currently on the market, Actos [pioglitazone] and Avandia [rosiglitazone], do not have the same risk for the liver dysfunction.
In communicating this information, it is important to note that patients with poorly controlled type 2 diabetes develop fatty liver, and treatment with drugs like Rezulin have been shown to improve the fatty liver.
DTQ-ONCGBDM20011001
Original posting 9 Oct 2001
Posted to Pills for Diabetes
advertisement
|
|
|||
Last Updated: Tuesday April 06, 2010 15:09:25
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by Children With Diabetes, Inc, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, Privacy Policy, and Safe Harbor Policy.
© Children with Diabetes, Inc. 1995-2013. Comments and Feedback.